29 research outputs found

    Morbidity following Ileal Conduit Urinary Diversion in a Welsh District Hospital over 10 years

    No full text
    Objective: To assess the post-operative morbidity after ileal conduit diversion at our institution. Patients and Methods: The records of 84 patients with a mean age of 62.1 (range 22 -89) years who underwent ileal conduit diversion at our institution between 1992 and 2002 were reviewed and all post-operative complications occurring later than 3 months after the intervention were analyzed. Results: Overall, 242 ileal conduit-related complications (71 major and 171 minor) developed in 72 of 84 patients (85.7%). The mean and median follow-up were 38.6 and 24 months, respectively (range 3 to 108 months). A total of 38 surgical procedures / interventions were needed in 33 patients (39.3%). 62/72 patients (86.1%) developed complications within the fi rst 5 years. 32 stoma-related complications were recorded in 22/84 (26.2%) patients. Fifty-nine percent (n=42) of the major complications occurred in the 30 patients who had been subjected to diversion for non-malignant indications and had a longer mean follow-up (4.5 years) than the 54 patients who had been operated for malignancy (mean follow-up 2.5 years). Conclusion: Patients with benign disease fared better in survival as expected, but the longer they survived, the higher was the incidence of complications and the re-intervention rate. In view of the high complication rate, especially in patients with a long life expectancy and benign conditions, objective guidelines regarding the choice of urinary diversion will help surgeons in decision making, patient selection and counseling. Keywords: Ileal conduit diversion, complications, urinary diversion, morbidity, adult, cancerAfrican Journal Of Urology Vol.14 (3) 2007: pp. 147-15

    Current concepts in the management of adrenal incidentalomas

    No full text
    Adrenal tumors are among the commonest incidental findings discovered. The increased incidence of diagnosing adrenal incidentalomas is due to the widespread availability and use of noninvasive imaging studies. Extensive research has been conducted to define a cost-effective diagnostic and therapeutic protocol to guide physicians in managing incidental adrenal lesions. However, there is little consensus on the optimal management strategy. Published literature to date, describes a wide spectrum of treatment options ranging from excision of all adrenal lesions regardless of the size and functional status to extensive hormonal and radiological evaluation to avoid surgery. In this review, we present a comprehensive overview of the presentation, evaluation and management of adrenal incidentalomas. Additionally, we propose a management algorithm to optimally manage these tumors

    Presentation and outcome following radical cystectomy in hispanics with bladder cancer

    No full text
    OBJECTIVE: Significant racial and ethnic differences in the epidemiology of bladder cancer (BC) exist. Studies have shown African Americans to have lower incidence of bladder cancer than Caucasians, but higher incidence of invasive BC. Hispanics are the largest minority group in the United States. However, no reported studies on bladder cancer among Hispanics are available to date. As our center is in a unique position to study BC in Hispanic patients we were prompted to assess presentation and outcome of patients undergoing radical cystectomy (RC) for BC. MATERIALS AND METHODS: Between January 1992 and May 2006, 448 RC were performed. All relevant data were collected and entered into a database. Patients were categorized by ethnicity as Hispanic and non-Hispanic White. African-American and other minority groups were excluded because of the small number. Comparative analysis of Hispanic and non-Hispanic White patients was performed. RESULTS: 67 (17%) patients were Hispanic. Mean follow-up period was 41 (SD ± 40) months. Clinical and pathological data between these two groups were compared. Pre-cystectomy T stage was not significantly different between both groups. However, after RC incidence of ≤ T1 disease in Hispanics was lower (22%) than Caucasians (37%). This difference, statistically significant (P = 0.024) indicates that Hispanics who undergo RC present with higher stage disease. Kaplan-Meier log rank test indicated a difference in disease free survival and disease specific survival between the two groups but however it did not reach statistical significance (Log Rank P = 0.082, P = 0.063). No significant difference in overall survival was observed (P = 0.465). CONCLUSIONS: Hispanic patients managed with RC for bladder carcinoma present with higher stage disease
    corecore